THEY MUST COLLABORATE!

( I, BY THE WAY ,WAS RESQUED AFTER KILLING BU bUSH PEOPLE WITH
DEFIBRILATOR USE; THE SUSPEICION IS THAT THEY WANT TO SECURE MY DEATH
AGAIN;  ON THE BOOK I AM OLD BUT IN LIFE - NOT; I NEED IT!)

Defibrillators may have little benefit for older, sicker patients |
HarvardScience

  WORK IN PROGRESS IN THE FIELD A LIFE IN SCIENCE resources:RECOVERY
  ACT FUNDING HARVARDSCIENCE MATTERS RESOURCE DIRECTORY HUSEC HARVARD
CATALYST -
  CTSC OFFICE OF TECHNOLOGY DEVELOPMENT EVENTS CALENDARS MOST EMAILED
FAQs
  HARVARDSCIENCE RSS HarvardScience is a publication of the Harvard
Office of News
and Public Affairs devoted to all matters related to science at the
various
schools, departments, institutes, and hospitals of Harvard
University.  medicine
+ health Patients under 65 years of age, and older patients without
other
      major illnesses, would be most likely to benefit from
defibrillators.
      Post this story to:
       del.icio.us Reddit Digg Slashdot Print Page
      Related StoriesNew data finds defibrillator recalls to be
commonť
      Study suggests pacemaker and defibrillator recalls on the riseť
      Related PeopleSoko Setoguchiť
      Related ProgramsBrigham and Women's Hospitalť
      Harvard Medical SchoolťHOME: MEDICINE+HEALTH
      Defibrillators may have little benefit for older, sicker
patientsMarch 16,
      2009
      Defibrillators are commonly recommended to patients with heart
failure to
      prevent sudden cardiac death, but beyond having heart failure,
there is a
      lack of criteria to identify the appropriate patients for this
therapy.
      Researchers at Brigham and Women’s Hospital (BWH) found that
older people
      with comorbidities and those with multiple hospital admissions
related to
      heart failure are unlikely to receive a meaningful survival
benefit from
      implanted defibrillators. These findings appear in the March 17
issue of
      the Canadian Medical Association Journal.
      Even if all out-of-hospital cardiac deaths were prevented by
implanted
      defibrillators, the researchers found that survival was
significantly
      lower in patients who were repeatedly hospitalized for heart
failure.
      Similarly, survival was poor for older patients with
comorbidities, such
      as cancer, dementia, and kidney disease. However, patients under
65 years
      of age and older patients without kidney disease, cancer, or
dementia
      would be most likely to benefit from defibrillators to prevent
sudden
      death.
      “Previous trials show significant benefits of defibrillators in
patients
      with heart failure, but the study populations typically exclude
elderly
      patients and those with comorbidities,” said Soko Setoguchi, of
the
      department of medicine at Brigham and Women’s Hospital (BWH).
      However, information from the U.S. National Cardiovascular Data
Registry
      from 2006 through 2007 indicates that defibrillators are
frequently
      implanted in patients with comorbidities, and 61 percent of
implanted
      defibrillators go to people aged 65 or older.
      The study looked at more than 14,000 patients admitted to a
hospital for
      heart failure from an administrative database. The average age
of the
      group was 77 years, and patients had a high prevalence of
comorbidities
      such as other cardiovascular disease, diabetes, chronic
pulmonary disease,
      and kidney disease. Researchers tracked the patients, recording
the number
      of hospital admissions due to heart failure, the development of
      comorbidities, and the cause of death, when appropriate.
      “Patients at extremely high risk of death, including patients
with prior
      heart failure hospitalizations and chronic disease, have such a
high risk
      of all-cause death that even if the potentially treatable sudden
cardiac
      deaths were prevented, the overall risk of death would remain
      prohibitively high,” notes Setoguchi.  "